The mechanism of action of inotuzumab ozogamicin - 101793

Spotlight
Video

The mechanism of action of inotuzumab ozogamicin

VJHemOnc has 1608 videos Subscribe Here

Loading........
Description: Giovanni Martinelli, MD, from the University of Bologna, Bologna, Italy discusses why inotuzumab ozogamicin is a promising drug and explains how it targets CD22. Inotuzumab is a calicheamicin-conjugated CD22 antibody and is able to selectively introduce small amount of chemotherapy into CDD22 positive cells.
Recorded at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
Shared By : VJHemOnc
Posted on : 04/15/16
Added : 3 years ago
Category : General